Peridialytic Hypotension
Conditions
Keywords
hemodialysis, dialysis, hypotension, CritLine, PiCCO, Thermodilution, CVVHDF, IHD
Brief summary
Currently, decisions regarding volume management for dialysis sessions in the ICU are made in large part on the nephrologists'/intensivists' overall gestalt. This gestalt is based upon a combination of commonly used measures of circulatory function, the physical exam, fluid balance, estimates of dialysis dry weight, and monitoring changes in relative blood volume status using devices such as the Crit-Line™ III, and central venous pressures. However, these tools perform poorly in predicting the circulatory system's overall response to dialysis. Consequently, episodes of dangerously low blood pressure are still frequently encountered. Better techniques to predict the circulatory system's response to dialysis are much needed. The intent of this study is to test newer metrics of circulatory system function for their ability to predict low blood pressure episodes during dialysis. This is important because it may enable the design of newer treatment strategies created to prevent low blood pressure episodes during dialysis and improve patient outcomes. The investigators overall hypothesis is that newer measures of vascular volume and dynamic indices of fluid responsiveness, previously found to better reflect cardiac preload state than currently used parameters, will better predict low blood pressure episodes during dialysis than current methods.
Interventions
A PiCCO femoral catheter will be placed and PiCCO parameters will be obtained using transpulmonary thermodilution after continuous dialysis is ordered or just prior to initiation of intermittent dialysis, hourly until either completion of intermittent dialysis or 8 hours of continuous dialysis is completed.
Sponsors
Study design
Eligibility
Inclusion criteria
* Admitted to OHSU Hospitals ICUs * Patient has acute or chronic needs for intermittent hemodialysis support during their ICU stay for any reason other than isolated hyperkalemia * Central venous access in place separate from the dialysis catheter, or arteriovenous fistula or graft * Two or more organ systems affected by critical illness requiring supportive care as documented in the medical chart.
Exclusion criteria
* age younger than 18 years old * Weight \> 160 kg * burns greater than 40% total body surface area * known cardiac or vascular aneurysm * contraindications to femoral arterial puncture * diagnosis of peripheral vascular disease * not committed to full support * participation in other experimental medication trial within 30 days * current atrial or ventricular arrhythmias * history of sever CHF- NYHA class \>= III, previously documented EF \< 30% * severe aortic regurgitation * anticipated ICU stay \< 24 hrs * not expected to require dialysis \> 48 hours
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| hypotensive episode | during or within one hour post dialysis | A mean arterial pressure of \<60 mmHg, a 15% decrease from baseline systolic blood pressure at the start of the dialysis treatment regardless of modality, the need for fluid bolusing \>7 mL/kg body weight, or initiation or increase of vasopressor medication in order to maintain MAP \>60 mmHg. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| predicted volume of fluid that can be removed without hypotensive events | during dialysis | Parameters measured will be examined to see if they can predict the volume of fluid successfully removed without hypotensive events |
| mortality in the ICU | duration of ICU stay | — |
| fluid removal tolerance | during the 4 hours following parameter measurement in dialysis | Parameters measured will be examined to discriminate between patients that will tolerate fluid removal (UF) during the following 4 hours of dialysis if UF is ordered by physician (no hypotensive events with \> 500 mL fluid removal) from those that won't |
| Length of stay in ICU | ICU stay duration | — |
| Length of stay in hospital | duration of hospital stay | — |
| All cause mortality | 30 days | — |
Countries
United States